Leeward Financial Partners, LLC Abb Vie Inc. Transaction History

Leeward Financial Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $2.21 Million - $2.75 Million	-16,692 Reduced 88.17%	2,239 $301,000
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $160,950 - $185,359	1,113 Added 6.25%	18,931 $3.02 Million
Q4 2022 Jan 30, 2023	BUY	$138.31 - $165.87 $65,835 - $78,954	476 Added 2.74%	17,818 $2.88 Million
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $76,902 - $88,201	573 Added 3.42%	17,342 $2.33 Million
Q2 2022 Jul 19, 2022	BUY	$137.62 - $174.96 $2.31 Million - $2.93 Million	16,769 New	16,769 $2.57 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Leeward Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Leeward Financial Partners, LLC with notifications on news.